Mapping Evidence of Pharmacy Services for COVID-19 in China
ObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy se...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.555753/full |
id |
doaj-1bf514f94d024dd987053429eea13a91 |
---|---|
record_format |
Article |
spelling |
doaj-1bf514f94d024dd987053429eea13a912020-11-25T03:55:36ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-10-011110.3389/fphar.2020.555753555753Mapping Evidence of Pharmacy Services for COVID-19 in ChinaZhan-Miao Yi0Zhan-Miao Yi1Zhan-Miao Yi2Yang Hu3Yang Hu4Yang Hu5Yang Hu6Guan-Ru Wang7Guan-Ru Wang8Guan-Ru Wang9Guan-Ru Wang10Rong-Sheng Zhao11Rong-Sheng Zhao12Rong-Sheng Zhao13Department of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaDepartment of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, ChinaDepartment of Pharmacy, Peking University Third Hospital, Beijing, ChinaInstitute for Drug Evaluation, Peking University Health Science Center, Beijing, ChinaTherapeutic Drug Monitoring and Clinical Toxicology Center, Peking University, Beijing, ChinaObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy services for COVID-19 patients using a predefined search strategy. The search period was from inception to April 7th 2020. We also manually searched the reference list of included articles and websites of important journals with special issues for COVID-19.ResultsA total of 156 articles were identified by applying the search criteria. After screening, 91 articles, with the majority are literature reviews (n = 77, 84.62%) published in Chinese (n = 83, 91.2%), were included. Pharmacist interventions for COVID-19 patients most commonly related to guidelines or consensus development for the treatment of disease and practice procedure to prevent the spread of COVID-19 (n = 10, 10.98%), the supply of medicines to treat patients with severe respiratory or systematic symptoms related to COVID-19 (n = 10, 10.98%), formulating infections prevention and control strategies related to COVID-19 for pharmaceutical personnel/pharmacy staff (n = 14, 15.39%), new way of delivery pharmacy services and the implementation of new pharmacy services for COVID-19 outbreak (n = 14, 15.39%), routine pharmacy services under the restrict limit of COVID-19 outbreak (n = 39, 42.86%), and case series analysis of treatment regimens using existing, routinely collected data (n = 4, 4.40%).ConclusionPharmacy services have a role in the COVID-19 pandemic control, and there were many rapid changes in response to the pandemic.https://www.frontiersin.org/article/10.3389/fphar.2020.555753/fullCOVID-19pharmacy serviceguideline developmentemergency supplyservice model innovationtreatment regimens |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Zhan-Miao Yi Zhan-Miao Yi Zhan-Miao Yi Yang Hu Yang Hu Yang Hu Yang Hu Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Rong-Sheng Zhao Rong-Sheng Zhao Rong-Sheng Zhao |
spellingShingle |
Zhan-Miao Yi Zhan-Miao Yi Zhan-Miao Yi Yang Hu Yang Hu Yang Hu Yang Hu Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Rong-Sheng Zhao Rong-Sheng Zhao Rong-Sheng Zhao Mapping Evidence of Pharmacy Services for COVID-19 in China Frontiers in Pharmacology COVID-19 pharmacy service guideline development emergency supply service model innovation treatment regimens |
author_facet |
Zhan-Miao Yi Zhan-Miao Yi Zhan-Miao Yi Yang Hu Yang Hu Yang Hu Yang Hu Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Guan-Ru Wang Rong-Sheng Zhao Rong-Sheng Zhao Rong-Sheng Zhao |
author_sort |
Zhan-Miao Yi |
title |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
title_short |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
title_full |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
title_fullStr |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
title_full_unstemmed |
Mapping Evidence of Pharmacy Services for COVID-19 in China |
title_sort |
mapping evidence of pharmacy services for covid-19 in china |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-10-01 |
description |
ObjectiveTo explore the role of pharmacists and innovation of pharmacy interventions for COVID-19 patients in China.MethodsWe comprehensively searched PubMed and Chinese databases Sinomed, China National Knowledge Infrastructure to identify articles reporting pharmacist interventions and pharmacy services for COVID-19 patients using a predefined search strategy. The search period was from inception to April 7th 2020. We also manually searched the reference list of included articles and websites of important journals with special issues for COVID-19.ResultsA total of 156 articles were identified by applying the search criteria. After screening, 91 articles, with the majority are literature reviews (n = 77, 84.62%) published in Chinese (n = 83, 91.2%), were included. Pharmacist interventions for COVID-19 patients most commonly related to guidelines or consensus development for the treatment of disease and practice procedure to prevent the spread of COVID-19 (n = 10, 10.98%), the supply of medicines to treat patients with severe respiratory or systematic symptoms related to COVID-19 (n = 10, 10.98%), formulating infections prevention and control strategies related to COVID-19 for pharmaceutical personnel/pharmacy staff (n = 14, 15.39%), new way of delivery pharmacy services and the implementation of new pharmacy services for COVID-19 outbreak (n = 14, 15.39%), routine pharmacy services under the restrict limit of COVID-19 outbreak (n = 39, 42.86%), and case series analysis of treatment regimens using existing, routinely collected data (n = 4, 4.40%).ConclusionPharmacy services have a role in the COVID-19 pandemic control, and there were many rapid changes in response to the pandemic. |
topic |
COVID-19 pharmacy service guideline development emergency supply service model innovation treatment regimens |
url |
https://www.frontiersin.org/article/10.3389/fphar.2020.555753/full |
work_keys_str_mv |
AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina AT zhanmiaoyi mappingevidenceofpharmacyservicesforcovid19inchina AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina AT yanghu mappingevidenceofpharmacyservicesforcovid19inchina AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina AT guanruwang mappingevidenceofpharmacyservicesforcovid19inchina AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina AT rongshengzhao mappingevidenceofpharmacyservicesforcovid19inchina |
_version_ |
1724469201468391424 |